Smoking and smoking cessation—The relationship between cardiovascular disease and lipoprotein metabolism: A review

doi:10.1016/j.atherosclerosis.2008.04.046

Atherosclerosis

Volume 201, Issue 2, December 2008, Pages 225-235

https://doi.org/10.1016/j.atherosclerosis.2008.04.046 Get rights and content

Abstract

Cigarette smoking is generally accepted as the most preventable cause of death in the United States today. Individuals who smoke experience a wide range of physiologic side effects that increase the risk of cardiovascular disease (CVD), including insulin resistance, elevated catecholamine levels which contribute to an elevated heart rate and blood pressure, and hypercholesterolemia.

The link between hypercholesterolemia and cardiovascular disease has been extensively researched and is undeniable. What is more, this link is strengthened in smokers as cigarette smoking is known to increase total cholesterol (TC), triglycerides (TG), and low-density lipoprotein (LDL), while acting to decrease the cardio-protective high-density lipoprotein (HDL). Alterations in the enzymes that control lipid transport may be a key underlying mechanism contributing to these health destroying effects.

This review examines the current literature related to: (1) smoking, lipoproteins, and lipid-related enzymes; (2) the impact of nicotine, carbon monoxide and free radicals on physiologic parameters related to health; and (3) metabolic issues involving smoking cessation and nicotine replacement therapy.

Introduction

Cardiovascular disease (CVD) is the leading cause of mortality and morbidity in the U.S. [1]. CVD is promoted by non-modifiable risk factors (genetic predisposition to the disease, age, and gender), as well as those that can be modified by lifestyle intervention. These include obesity, hypertension, hypercholesterolemia, diabetes, lack of physical activity and cigarette smoking.

Trends within the past 15 years suggest that every year since 1991 the prevalence of modifiable risk factors has increased and is reflected in the number of individuals who refrain from physical activity [2] and who are classified as obese [3]. Moreover, the incidence of individuals who start smoking is on the rise again after a noticeable drop, and this is particularly prevalent among children, especially students in the 8th, 10th, and 12th grades [4].

Atherosclerosis, the underlying cause of CVD, is greatly enhanced by abnormal plasma lipid and lipoprotein profiles. Such profiles are characterized in the Third Report of the National Cholesterol Education Program [5] as demonstrating one or more of the following:

•
low-density lipoprotein (LDL) > 100 mg/dL;
•
triglyceride (TG) > 200 mg/dL;
•
total cholesterol (TC) > 200 mg/dL;
•
high-density lipoprotein (HDL) < 40 mg/dL.

Individuals are placed into risk categories based on LDL measurements and identification of accompanying risk determinants, including smoking, hypertension, low HDL, family history and age [5]. The health destroying impact of lipoprotein abnormalities escalates markedly when combined with cigarette smoking. What is more, smoking exacerbates the degree of lipoprotein abnormality, thus contributing in a sense to a deadly spiraling effect. The purpose of this review was to examine the impact of cigarette smoking on lipoprotein metabolism and related issues.

Section snippets

CVD and cholesterol

Several large cohort studies have examined the effects of modifiable risk factors on CVD. The Framingham, Oslo, Helsinki, and Bogalusa Heart Studies as well as the Multiple Risk Factor Intervention Trials (MRFIT) were all designed to examine the etiology of CVD and, perhaps more important, how to reduce its prevalence [6], [7], [8], [9], [10].

The Framingham Heart Study initiated in 1948 was among the first to reveal a relationship between the incidence of atherosclerosis and higher blood

CVD and cigarette smoking

Cigarette advertisements were seen as early as 1913 and specifically targeted women, coaxing them to smoke rather than indulge in satisfying their sweet tooth. From there the surge of advertising was immense, especially during World War I and the Great Depression. Cigarettes had become more “palatable” as the former harsh tobaccos from Turkey were being replaced with milder brands. Smoking rates accelerated during the War as cigarettes were easier to manage than a pipe, and the government

Cigarette smoking impacts lipids and lipoproteins

A comprehensive meta-analysis by Craig et al. [26] examined published data from 1966 to 1987 and estimated the excess risk posed by smoking on CVD, with particular emphasis on lipid and lipoprotein involvement. Results of their analysis indicated that individuals who smoked cigarettes when compared with non-smokers had significantly higher TC (3%), TG (9.1%), and VLDL (10.4%), higher (but not significant LDL (1.7%), and lower concentrations of HDL (−5.7%) and apolipoprotein AI (Apo A-I)

Cigarette smoking and lipid metabolism

Cigarette smoking is detrimental to health and contributes to CVD via alterations in the lipid profile, and in particular the impact on HDL. One popular explanation is that cigarette particulate matter alters catecholamine release—and thus free fatty acid release, which in turn affects VLDL and LDL concentrations to favor their accumulation in the blood, contributing to a lower HDL concentration [35]. Ultimately cigarette smoking seriously disrupts lipid and lipoprotein metabolism, promoting

Cigarette smoking, HDL, subfractions and enzymes

Cigarette smoking exerts a negative effect on HDL, causing a 5.7% decrease in concentration. This would impede reverse cholesterol transport, a process that removes excess cholesterol from the blood and transports it to the liver for catabolism [26]. HDL works in concert with three key enzymes:

Lecithin cholesterol acyl-transferase (LCAT) esterifies free cholesterol in the presence of ApoA-I and promotes the movement of esterified cholesterol into the HDL core.

Cholesterol ester transfer protein

Dose–response relationship between smoking and lipoproteins

In the meta-analysis conducted by Craig et al. [26], they compared non-smokers, to light, moderate, and heavy smokers and found a dose–response relationship between the number of cigarettes smoked and the change in lipid or lipoprotein variable. Their results indicated a progressive increase (%) as the smoking dosage increased from none to heavy: TC (0, +0.8, +4.3 and +4.5%), TG (0, +10.7, +11.5 and +18.0%), VLDL (0, +7.2, +44.4, and +39.0%), and LDL (0, −1.1, −1.4 and +11.0%). They also

Beyond the lipid profile

Although the focus of this review is on the influence of smoking on lipids and lipoproteins, it would be remiss to report that physiological perturbations as a result of smoking are limited to the lipid profile. Other mechanisms affected by cigarette smoke may also contribute to accelerating atherosclerotic lesion formation such as vasomotor and platelet dysfunction, inflammation, alterations in fibrinolysis, antithrombotic and prothrombotic factors. These are integral parts for both the

Gender differences in cigarette smoking and CVD

It is important to briefly mention the sex differences that potentially exist between males and females with regards to smoking and the incidence of CVD. A recent study by Vidrine et al. [80] examined gender differences in adolescents on smoking outcomes and found that there were significant differences in smoking behavior. Specifically, boys smoked because of the buzz, pleasure, taste/smell or stimulation and did not smoke because of impairment of sport. Girls’ major reasoning for smoking was

Smoking cessation and nicotine replacement therapy

The World Health Organization's MONICA project reaffirmed in 2000 that cigarette smoking was one of the most powerful factors contributing to CVD [84], and smoking cessation is strongly recommended. Early studies [23], [24] reported that those individuals who quit smoking had a substantial decrease in risk for acute myocardial infarction as compared to those who continued to smoke. Since 1970, several studies have affirmed that the decrease in incidence of CVD and acute myocardial infarction is

Metabolic changes after smoking cessation

The cessation of smoking will initially result in a metabolic withdrawal syndrome that affects 80% of all smokers [102], [103]. Symptoms include restlessness, irritability, anxiety, and confusion. The impact of such symptoms are compounded by weight gain, an increase in waist to hip ratio, and an increased percent body fat due to increased caloric intake and/or decreased resting metabolic rate [48], [57], [94], [104], [105], [106].

Does HDL-C normalization occur despite weight gain? The answer

Conclusions

Cigarette smoking is a major risk factor for CVD and exerts negative effects on the lipid and lipoprotein profile. Research indicates that at any given level of serum TC the relative risk for CVD and all-cause mortality is significantly higher in smokers, ranging from 1.57 to 2.78, and is evident even among those smokers who demonstrate a favorable TC concentration. Smoking decreases the cardio-protective HDL-C and may increase levels of TC, TG and LDL-C. Furthermore, cigarette smoking can

References (110)

P.B. Johnson et al.
The relationship between smoking, drinking, and adolescents self-perceived health and frequency of hospitalization: analysis from the 1997 National Household Survey on Drug Abuse
J Adolesc Health
(2002)
N.E. Miller
The Tromoso heart study. High density lipoprotein and coronary heart disease: a prospective case–control study
Lancet
(1977)
H.C. McGill
The cardiovascular pathology of smoking
Am Heart J
(1988)
F.S. Facchini et al.
Insulin resistance and cigarette smoking
Lancet
(1992)
C. Kong et al.
Smoking is associated with increased hepatic lipase activity, insulin resistance, dyslipidemia and early atherosclerosis in type 2 diabetes
Atherosclerosis
(2001)
B.A. Griffin et al.
Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small dense LDL to coronary heart disease risk
Atherosclerosis
(1994)
L.J. van Tits et al.
Effects of alpha-tocopherol on superoxide production and plasma intercellular adhesion molecule-1 and antibodies to oxidized LDL in chronic smokers
Free Rad Biol Med
(2001)
N.M. Shennan et al.
Variation in serum lipid and lipoprotein levels associated with changes in smoking behavior in non-obese Caucasian males
Atherosclerosis
(1985)
R.J. Moffatt et al.
Effects of the transdermal nicotine patch on normalization of HDL-C and its subfractions
Prev Med
(2000)
K. Berg et al.
Effect of smoking on serum levels of HDL apoproteins
Atherosclerosis
(1979)

B.A. Stamford et al.

Cigarette smoking, physical activity, and alcohol consumption: relationship to blood lipids and lipoproteins in premenopausal females

Metabolism

(1984)

J. Tuomilehto et al.

Effects of smoking and stopping smoking on serum high density lipoprotein cholesterol levels in a representative population sample

Prev Med

(1986)

J.E. Muscat et al.

Cigarette smoking and plasma cholesterol

Am Heart J

(1991)

M.S. Green et al.

A prospective study on the effects of changes in smoking habits of blood count, serum lipids and lipoproteins, body weight and blood pressure in occupationally active men, the Israeli Cordis Study

J Clin Epidemiol

(1995)

C.J. Smith et al.

Particulate and vapor phase constituents of cigarette mainstream smoke and risk of myocardial infarction

Atherosclerosis

(2001)

J.A. Ambrose et al.

The pathophysiology of cigarette smoking and cardiovascular disease: an update

J Am Coll Cardiol

(2004)

P. Astrup et al.

Model studies linking carbon monoxide and/or nicotine to arteriosclerosis and cardiovascular disease

Prev Med

(1979)

A. Penn et al.

Inhalation of carbon monoxide does not accelerate arteriosclerosis in cockerels

Eur J Pharmacol

(1992)

S. Zevin et al.

Cardiovascular effects of carbon monoxide and cigarette smoking

J Am Coll Cardiol

(2001)

D. Blache et al.

Acute influence of smoking on platelet behviour, endothelium and plasma lipids and normalization by aspirin

Atherosclerosis

(1992)

X.L. Wang et al.

Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity

FEBS Lett

(2000)

A.V. Diez-Roux et al.

The relationship of active and passive smoking to carotid atherosclerosis 12–14 years later

Prev Med

(1995)

J.M. Schmitz

Smoking cessation in women with cardiac risk

Am J Med Sci

(2003)

K. Kuulasmaa et al.

Estimation of contribution of changes in classic risk factors to trends in coronary event rates across WHO MONICA project populations

Lancet

(2000)

A. Tverdal et al.

Mortality in relation to smoking history: 13 years follow-up of 68,000 Norwegian men and women 35–49 years old

J Clin Epidemiol

(1993)

K. Maeda et al.

The effects of cessation from cigarette smoking on the lipid and lipoprotein profiles: a meta-analysis

Prev Med

(2003)

B.A. Stamford et al.

Effects of smoking cessation on weight gain, metabolic rate, caloric consumption and blood lipids

Am J Clin Nutr

(1986)

R.J. Moffatt

Effects of cessation of smoking on serum lipids and high density lipoprotein cholesterol

Atherosclerosis

(1988)

M. Quensel et al.

High density lipoprotein concentrations after cessation of smoking: the importance of alterations in diet

Atherosclerosis

(1989)

S.S. Allen et al.

Cholesterol changes in smoking cessation using the transdermal nicotine system. Transdermal Nicotine Study Group

Prev Med

(1994)

W. Rosamond

Heart Disease and Stroke Statistics—2007, update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

Circulation

(2007)

US Department of Health and Human Services. Reducing tobacco use: a report of the Surgeon General. Atlanta, GA: US...

R.P. Troiano et al.

Overweight prevalence among youth in the US. Why so many different numbers?

Int J Obes Rel Met Dis

(1999)

National Cholesterol Education Program. Third report of the expert panel on detection, evaluation, and treatment of...

W.B. Kannel et al.

Risk factors in coronary heart disease. An evaluation of several serum lipids as predictors of coronary heart disease. The Framingham Study

Ann Intern Med

(1964)

M. Roma

Factors related to sudden death in acute ischaemic heart disease. A community study in Helsinki

Acta Med Scand Suppl

(1972)

I. Holme

Coronary risk factors and their possible causal role in the development of coronary heart disease: the Oslo study

J Oslo City Hosp

(1982)

S.R. Srinivasan et al.

Lipid composition and interrelationships of major serum lipoproteins. Observations in children with different lipoprotein profiles. Bogalusa Heart Study

Arteriosclerosis

(1982)

MRFIT Research Group

Relationship between baseline risk factors and coronary heart disease and total mortality in the Multiple Risk Factor Intervention Trial (MRFIT)

Prev Med

(1986)

T.R. Dawber et al.

Coronary heart disease in the Framingham Study

Am J Pub Health

(1957)

M.H. Criqui et al.

Cigarette smoking and plasma high density lipoprotein cholesterol. The Lipid Research Clinics Program Prevalence Study

Circulation

(1980)

W.B. Kannel

Cardiovascular risk assessment

T. Gordon et al.

Premature mortality from coronary heart disease

JAMA

(1971)

A. Kagan et al.

Coronary heart disease among men of Japanese ancestry in Hawaii. The Honolulu Heart study

Isr J Med Sci

(1971)

G.M. Kostner

Apolipoproteins and lipoproteins of human plasma: significance in health and disease

Adv Lipid Res

(1983)

National Health Interview Survey, selected years—United States. Number (in millions) of adults 18 years and older who...

National Health Interview Survey (NHIS). Centers for Disease Control and Prevention, National Center for Health...

Huchard H. Maladies du Coeur et des vaisseaux. Treaty of Cardiology. Paris Doin;...

T. Lewis

Diseases of the heart

(1933)

S.A. Levine

Clinical heart disease

(1950)

Cited by (249)

Cost-Effectiveness of a Comprehensive Primary Care Smoking Treatment Program
2024, American Journal of Preventive Medicine
Smoking is the leading preventable cause of death and disease in the U.S. This study evaluates the cost-effectiveness from a healthcare system perspective of a comprehensive primary care intervention to reduce smoking rates.
This pragmatic trial implemented electronic health record prompts during primary care visits and employed certified tobacco cessation specialists to offer proactive outreach and smoking cessation treatment to patients who smoke. The data, analyzed in 2022, included 10,683 patients in the smoking registry from 2017 to 2020. Pre–post analyses compared intervention costs to treatment engagement, successful self-reported smoking cessation, and acute health care utilization (urgent care, emergency department visits, and inpatient hospitalization). Cost per quality-adjusted life year was determined by applying conversion factors obtained from the tobacco research literature to the cost per patient who quit smoking.
Tobacco cessation outreach, medication, and counseling costs increased from $2.64 to $6.44 per patient per month, for a total post-implementation intervention cost of $500,216. Smoking cessation rates increased from 1.3% pre-implementation to 8.7% post-implementation, for an incremental effectiveness of 7.4%. The incremental cost-effectiveness ratio was $628 (95% CI: $568, $695) per person who quit smoking, and $905 (95% CI: $822, $1,001) per quality-adjusted life year gained. Acute health care costs decreased by an average of $42 (95% CI: −$59, $145) per patient per month for patients in the smoking registry.
Implementation of a comprehensive and proactive smoking cessation outreach and treatment program for adult primary care patients who smoke meets typical cost-effectiveness thresholds for healthcare.
Exploring cardiac impact of oral nicotine exposure in a transplantable Neoplasm Mice Model: Insights from biochemical analysis, morphometry, and molecular docking: Chlorella vulgaris green algae support
2023, Toxicology
Nicotine-induced cardiac tissue damage is a concern for cancer patients, but the exact pathogenesis from nicotine oral exposure is unclear. This study was designed to investigate the impact of nicotine and Chlorella vulgaris (Ch. V) on cardiac glutathione homeostasis, inflammatory response, cardiac damage markers, apoptotic proteins and histopathological findings in an experimentally transplantable neoplasm mouse model (Ehrlich ascites carcinoma; EAC). In the in-vivo experiment, the female Swiss mice were divided into four groups: control, Ch.V (100 mg/kg), Nicotine (100 µg/ml/kg), and a combination group ( Nocotine+ Ch.V) for 40 days. Furthermore, in this study,the effects of C. vulgaris components on caspase-3, TNF-α, and IL-1β activity were explored using Molecular Operating Environment (MOE) docking software to ensure its ability to counteract the toxic effects of nicotine. The results indicated that nicotine has induced significant (P < 0.001) cardiopathic alterations in EAC-bearing mice with changes in cardiac tissue enzymes. C. Vulgaris attenuated the nicotine-induced cardiac glutathione inhibition, suppressed the inflammatory response, exerted antiapoptotic effects, mitigated myocardial injury biomarkers, and repaired cellular and tissue damage. Moreover, the molecular docking results revealed the ability of C. vulgaris to bind with interleukin-1 receptor type 1 (IL1R1) and tumor necrosis factor receptor superfamily member 1 A (TNFRSF1A) in the mice tissues, ameliorating apoptosis and inflammatory processes associated with nicotine-induced cardiotoxicity. This study provides a model for understanding nicotine-induced myocardial injury during experimentally transplantable neoplasm. It highlights C. vulgaris as a beneficial food supplement for cancer patients exposed to nicotine orally.
Associations between e-cigarette use or dual use of e-cigarette and combustible cigarette and metabolic syndrome: results from the National Health and Nutrition Examination Survey (NHANES)
2023, Annals of Epidemiology
Examine associations between e-cigarette use or dual use of e-cigarette and combustible cigarette and metabolic syndrome (MetS).
Cross-sectional data of 5121 U.S. adults from the National Health and Nutrition Examination Survey were analyzed. Weighted multivariable Poisson regression models were used to examine associations between e-cigarette use or dual use and MetS and its components. Prevalence ratios (PRs) with 95% confidence intervals (95% CI) were estimated.
Current and former e-cigarette users were 30% (95% CI: 1.13, 1.50) and 15% (95% CI: 1.03, 1.28) more likely to have MetS than never e-cigarette users. Current or former e-cigarette use was also associated with elevated triglycerides, reduced high-density lipoprotein (HDL) cholesterol, and elevated blood pressure (AOR ranged from 1.15 to 1.42, all P < 0.05). The prevalence of MetS for dual users was 1.35-fold (95% CI: 1.15, 1.58) higher than that for never smokers and 1.21-fold (95% CI: 1.00, 1.46) higher than that for combustible cigarette-only users. Dual users were also more likely to report elevated triglycerides and reduced HDL cholesterol than never smokers or combustible cigarette-only users (all P < 0.05).
E-cigarette use or dual use is associated with MetS. Our findings may inform tobacco control policies regarding regulations of e-cigarette use.
A critical review on air pollutant exposure and age-related macular degeneration
2022, Science of the Total Environment
Age-related macular degeneration (AMD) is the leading cause of visual impairments and blindness worldwide in the elderly and its incidence strongly increases with ages. The etiology of AMD is complex and attributed to the genetic modifiers, environmental factors and gene-environment interactions. Recently, the impacts of air pollution on the development of eye diseases have become the new area of focus, and disordered air exposure combined with inadequate health management has caused problems for the eye health, such as dry eye, glaucoma, and retinopathy, while its specific role in the occurrence of AMD is still not well understood. In order to summarize the progress of this research field, we performed a critical review to summarize the epidemiological and mechanism evidence on the association between air pollutants exposure and AMD. This review documented that exposure to air pollutants will accelerate or worsen the morbidity and prevalence of AMD. Air pollutants exposure may change the homeostasis, interfere with the inflammatory response, and take direct action on the lipid metabolism and oxidative stress in the macula. More attention should be given to understanding the impact of ambient air pollution on AMD worldwide.
Comparative effectiveness of gastric bypass and sleeve gastrectomy on predicted 10-year risk of cardiovascular disease 5 years after surgery
2022, Surgery for Obesity and Related Diseases
Citation Excerpt :
In addition, there have been reports of addiction transference in bariatric patients who may substitute smoking, alcohol, and other drugs, for food after surgery [38–40]. Smoking is one of the strongest modifiable predictors of CVD [41]. This underscores the importance of postoperative monitoring and support for bariatric patients who might experience a number of unintended negative consequences following surgery including substance use disorder [38], suicide [39], and disordered eating [40].
Comparative evidence is needed when deciding which bariatric operation to undergo for long-term cardiovascular risk reduction.
The Effectiveness of Gastric Bypass vs. Gastric Sleeve for Cardiovascular Disease (ENGAGE CVD) study compared the effectiveness of vertical sleeve gastrectomy (VSG) and Roux-en-Y gastric bypass (RYGB) operations for reduction of the American College of Cardiology and the American Heart Association–predicted 10-year atherosclerotic cardiovascular disease (ASCVD) risk 5 years after surgery.
Data for this study came from a large integrated healthcare system in the Southern California region of the United States. This is one of the most ethnically diverse (64% non-White) bariatric populations in the literature.
The ENGAGE CVD cohort consisted of 22,095 patients who underwent VSG or RYGB from 2009–2016. The VSG and RYGB were compared using a local instrumental variable approach to address observed and unobserved confounding, as well as to conduct heterogeneity of treatment effects for patients of different age groups, baseline-predicted 10-year CVD risk using the ASCVD risk score, and those who had type 2 diabetes (T2D) at the time of surgery.
Patients (2771 RYGB and 6256 VVSG) were primarily women (80.6%), Hispanic or non-Hispanic Black (63.7%), and 46 ± 10 years of age, with a body mass index of 43.40 ± 6.5 kg/m². The predicted 10-year ASCVD risk at surgery was 4.1% for VSG and 5.1% for RYGB, decreasing to 2.6% for VSG and 2.8% for RYGB 1 year postoperatively. By 5 years after surgery, patients remained with relatively low risk levels (3.0% for VSG and 3.3% for RYGB) and there were no significant differences in predicted 10-year ASCVD risk between VSG and RYGB at any time.
Predicted 10-year ASCVD risk was low in this population and remained low up to 5 years for those with diabetes, Black and Hispanic patients, and older adults. Literature reporting significant differences between VSG and RYGB in 10-year ASCVD risk may be a result of residual confounding.
Prevalence of depression, anxiety, and stress in cardiovascular patients: A case-control study
2024, Research Square

View all citing articles on Scopus

View full text

ReviewSmoking and smoking cessation—The relationship between cardiovascular disease and lipoprotein metabolism: A review

Abstract

Introduction

Section snippets

CVD and cholesterol

CVD and cigarette smoking

Cigarette smoking impacts lipids and lipoproteins

Cigarette smoking and lipid metabolism

Cigarette smoking, HDL, subfractions and enzymes

Dose–response relationship between smoking and lipoproteins

Beyond the lipid profile

Gender differences in cigarette smoking and CVD

Smoking cessation and nicotine replacement therapy

Metabolic changes after smoking cessation

Conclusions

J Adolesc Health

Lancet

Am Heart J

Lancet

Atherosclerosis

Atherosclerosis

Free Rad Biol Med

Atherosclerosis

Prev Med

Atherosclerosis

Metabolism

Prev Med

Am Heart J

J Clin Epidemiol

Atherosclerosis

J Am Coll Cardiol

Prev Med

Eur J Pharmacol

J Am Coll Cardiol

Atherosclerosis

FEBS Lett

Prev Med

Am J Med Sci

Lancet

J Clin Epidemiol

Prev Med

Am J Clin Nutr

Atherosclerosis

Atherosclerosis

Prev Med

Heart Disease and Stroke Statistics—2007, update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

Circulation

Overweight prevalence among youth in the US. Why so many different numbers?

Int J Obes Rel Met Dis

Risk factors in coronary heart disease. An evaluation of several serum lipids as predictors of coronary heart disease. The Framingham Study

Ann Intern Med

Factors related to sudden death in acute ischaemic heart disease. A community study in Helsinki

Acta Med Scand Suppl

Coronary risk factors and their possible causal role in the development of coronary heart disease: the Oslo study

J Oslo City Hosp

Lipid composition and interrelationships of major serum lipoproteins. Observations in children with different lipoprotein profiles. Bogalusa Heart Study

Arteriosclerosis

Relationship between baseline risk factors and coronary heart disease and total mortality in the Multiple Risk Factor Intervention Trial (MRFIT)

Prev Med

Coronary heart disease in the Framingham Study

Am J Pub Health

Cigarette smoking and plasma high density lipoprotein cholesterol. The Lipid Research Clinics Program Prevalence Study

Circulation

Cardiovascular risk assessment

Premature mortality from coronary heart disease

JAMA

Coronary heart disease among men of Japanese ancestry in Hawaii. The Honolulu Heart study

Isr J Med Sci

Apolipoproteins and lipoproteins of human plasma: significance in health and disease

Adv Lipid Res

Diseases of the heart

Clinical heart disease

Review
Smoking and smoking cessation—The relationship between cardiovascular disease and lipoprotein metabolism: A review